Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Inspire Medical Systems develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [4]. Lawsuit Details - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Inspire stock, with the case pending in the U.S. District Court for the District of Minnesota [3]. - Investors have until January 5, 2026, to request to be appointed to lead the case [3]. Stock Performance and Issues - Inspire assured investors that it had taken necessary steps for the launch of Inspire V, but failed to prepare clinicians and payors, leading to significant delays and weak demand [5][6]. - On August 4, 2025, Inspire disclosed an "elongated timeframe" for the Inspire V launch and reduced its 2025 earnings per share guidance by over 80%, attributing this to undisclosed factors including incomplete training at implanting centers and poor demand due to excess inventory of older devices [7]. - Following this announcement, Inspire's stock price dropped by $42.04 per share, or more than 32%, from $129.95 on August 4, 2025, to $87.91 on August 5, 2025 [8].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [2]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of CarMax investors [2]. Group 2: Company Performance and Stock Impact - CarMax reported disappointing financial results for Q2 of fiscal year 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [5]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million the previous year, attributed to a "pull forward" in demand due to U.S. tariffs [5]. - Following the financial report, CarMax's stock dropped $11.45 per share, or roughly 20%, from $57.05 on September 24, 2025, to $45.60 on September 25, 2025 [6]. - An unexpected departure of CEO Bill Nash on November 6, 2025, and a weak preliminary Q3 outlook led to an additional stock drop of over 24% [6]. Group 3: Company Background - CarMax is a leading retailer of used cars, emphasizing a seamless customer experience and strong demand for its vehicles [3]. - The law firm Bleichmar Fonti & Auld LLP, which is representing the plaintiffs, has a notable track record in securities class actions and has recovered significant amounts for investors in previous cases [10].

SAN DIEGO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Cogent Communications Holdings, Inc. (NASDAQ: CCOI) focused on whether Cogent Communications and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Cogent Communications investigation or if you are a Cogent Communications inv ...

Core Viewpoint - Kaskela Law LLC has initiated an investigation into Atkore Inc. to assess potential violations of securities laws or breaches of fiduciary duties by the company and its executives in relation to recent corporate actions [1]. Group 1 - The investigation is being conducted on behalf of Atkore's shareholders [1]. - Shareholders are encouraged to reach out to Kaskela Law LLC for more information regarding their legal rights and options [2]. - Kaskela Law LLC specializes in representing investors in cases of securities fraud, corporate governance, and merger & acquisition litigation [2].

PHILADELPHIA, Dec. 23, 2025 /PRNewswire/ -- Kaskela Law LLC announces that it has launched an investigation of Select Medical Holdings Corporation (NYSE: SEM) ("Select Medical") on behalf of the company's shareholders. The investigation seeks to determine whether Select Medical and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Select Medical shareholders are encouraged to contact Kaskela Law LLC (D. Seamus ...

Group 1 - Halper Sadeh LLC is investigating Clearwater Analytics Holdings, Inc. and Janus Henderson Group plc for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their respective sales [1][2] - Clearwater Analytics is being sold to Permira and Warburg Pincus for $24.55 per share in cash, while Janus Henderson is being sold to Trian Fund Management and General Catalyst for $49.00 per share in cash [1][2] - The firm may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders, operating on a contingent fee basis [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC free of charge to discuss their legal rights and options [4] - The firm represents investors globally who have experienced securities fraud and corporate misconduct, having recovered millions for defrauded investors [4]

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Charming Medical Limited ("Charming†or the "Company†) (NASDAQ: MCTA) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CHARMING MEDICAL LIMITED (MCTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 11, 2025, after market hours, the SEC issu. ...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of SLM Corporation a/k/a Sallie Mae ("SLM†or the "Company†) (NASDAQ: SLM) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SLM CORPORATION (SLM), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On August 14, 2025, investment bank TD Cowen issued a report s. ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SPROUTS FARMERS MARKET, INC. (SFM), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE JANUARY 26, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. BENSALEM, Pa., Dec. 22, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Sprouts Farmers Market, Inc. ("Sprouts" or the "Company") (NASDAQ: SFM). Cont ...

KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company's securities between October 28, 2024, and October 27, 2025, inclusive (the "Class Period†). This act. NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF†) and ...